On the plus side, there are a few things to be optimistic about. They have a fair amount of cash on hand, enough to fund operations for a while. So, as long as they are in business they have the opportunity to keep moving forward with positive developments. I don't think anybody here is happy about the missed timelines to date, but the potential is still there. They do not have debt, they can raise additional cash (with some dilution and possibly at the expense of the share price), the science has been proving out, they seem to be going forward, albeit slowly, with FDA intentions and other country possibilities. I don't see any near-term catalysts for share price increases, unless specific news on Australia, actual construction beginning on the facility, government awards, any tangible developments on the other fronts (dengue, herpes, EKC, etc.), occur. So, unfortunately, we may be in a holding period for six months to a year. Does anyone else see any catalysts for upward share price movement in the year 2013? If NNVC ever does get into human testing, and the science proves out, then down this very long road we may all be rewarded for our patience. It's just been and is going to have been a very long road!
Lee
Market Data 
Markets 
AI
